Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1996 Jun;70(6):3385–3391. doi: 10.1128/jvi.70.6.3385-3391.1996

Serine 3 is critical for phosphorylation at the N-terminal end of the nucleoprotein of influenza virus A/Victoria/3/75.

M Arrese 1, A Portela 1
PMCID: PMC190210  PMID: 8648669

Abstract

The influenza A virus nucleoprotein (NP) is a phosphoprotein that encapsidates the viral genomic RNA. To map the in vivo phosphorylation site(s) of this protein, 32P-labeled NP was purified from cell cultures infected with influenza virus A/Victoria/3/75 by immunoaffinity chromatography. The purified protein was then subjected to chemical digestion with formic acid, which cleaves proteins at Asp-Pro bonds, and the resulting products were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Two of the phosphorylated products obtained were identified as fragments corresponding to the N-terminal 88 amino acids and to the C-terminal 196 residues of the NP. To identify the phosphate acceptor site(s) at the N-terminal phosphorylated region of NP, each of the seven serines within this region was individually changed to alanine by site-directed mutagenesis. The mutant proteins were then transiently expressed in mammalian cells and analyzed for their phosphorylation state. It was observed that the S-to-A mutation at position 3 drastically reduced the amount of 32P label incorporated into NP, whereas the other substitutions did not have a discernible effect on the phosphorylation level of the protein. In addition, all serine-altered proteins were tested for their functionality in an artificial system in which expression of a synthetic chloramphenicol acetyl-transferase RNA molecule is driven by influenza virus proteins synthesized from cloned genes. The results obtained demonstrate that all mutant proteins were competent to cooperate with the subunits of the viral polymerase for expression of the synthetic virus-like chloramphenicol acetyltransferase RNA in vivo. These data are discussed regarding the possible roles of NP phosphorylation for the viral replicative cycle.

Full Text

The Full Text of this article is available as a PDF (530.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albo C., Valencia A., Portela A. Identification of an RNA binding region within the N-terminal third of the influenza A virus nucleoprotein. J Virol. 1995 Jun;69(6):3799–3806. doi: 10.1128/jvi.69.6.3799-3806.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Almond J. W., Felsenreich V. Phosphorylation of the nucleoprotein of an avian influenza virus. J Gen Virol. 1982 Jun;60(Pt 2):295–305. doi: 10.1099/0022-1317-60-2-295. [DOI] [PubMed] [Google Scholar]
  3. Barik S., Banerjee A. K. Sequential phosphorylation of the phosphoprotein of vesicular stomatitis virus by cellular and viral protein kinases is essential for transcription activation. J Virol. 1992 Feb;66(2):1109–1118. doi: 10.1128/jvi.66.2.1109-1118.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Baudin F., Bach C., Cusack S., Ruigrok R. W. Structure of influenza virus RNP. I. Influenza virus nucleoprotein melts secondary structure in panhandle RNA and exposes the bases to the solvent. EMBO J. 1994 Jul 1;13(13):3158–3165. doi: 10.1002/j.1460-2075.1994.tb06614.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Beaton A. R., Krug R. M. Transcription antitermination during influenza viral template RNA synthesis requires the nucleocapsid protein and the absence of a 5' capped end. Proc Natl Acad Sci U S A. 1986 Sep;83(17):6282–6286. doi: 10.1073/pnas.83.17.6282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bárcena J., Ochoa M., de la Luna S., Melero J. A., Nieto A., Ortín J., Portela A. Monoclonal antibodies against influenza virus PB2 and NP polypeptides interfere with the initiation step of viral mRNA synthesis in vitro. J Virol. 1994 Nov;68(11):6900–6909. doi: 10.1128/jvi.68.11.6900-6909.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Compans R. W., Content J., Duesberg P. H. Structure of the ribonucleoprotein of influenza virus. J Virol. 1972 Oct;10(4):795–800. doi: 10.1128/jvi.10.4.795-800.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Davey J., Dimmock N. J., Colman A. Identification of the sequence responsible for the nuclear accumulation of the influenza virus nucleoprotein in Xenopus oocytes. Cell. 1985 Mar;40(3):667–675. doi: 10.1016/0092-8674(85)90215-6. [DOI] [PubMed] [Google Scholar]
  9. Duesberg P. H. Distinct subunits of the ribonucleoprotein of influenza virus. J Mol Biol. 1969 Jun 28;42(3):485–499. doi: 10.1016/0022-2836(69)90237-x. [DOI] [PubMed] [Google Scholar]
  10. Fanning E. Control of SV40 DNA replication by protein phosphorylation: a model for cellular DNA replication? Trends Cell Biol. 1994 Jul;4(7):250–255. doi: 10.1016/0962-8924(94)90123-6. [DOI] [PubMed] [Google Scholar]
  11. Fuerst T. R., Niles E. G., Studier F. W., Moss B. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc Natl Acad Sci U S A. 1986 Nov;83(21):8122–8126. doi: 10.1073/pnas.83.21.8122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gao Y., Lenard J. Multimerization and transcriptional activation of the phosphoprotein (P) of vesicular stomatitis virus by casein kinase-II. EMBO J. 1995 Mar 15;14(6):1240–1247. doi: 10.1002/j.1460-2075.1995.tb07107.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Garcia-Barreno B., Delgado T., Akerlind-Stopner B., Norrby E., Melero J. A. Location of the epitope recognized by monoclonal antibody 63G on the primary structure of human respiratory syncytial virus G glycoprotein and the ability of synthetic peptides containing this epitope to induce neutralizing antibodies. J Gen Virol. 1992 Oct;73(Pt 10):2625–2630. doi: 10.1099/0022-1317-73-10-2625. [DOI] [PubMed] [Google Scholar]
  14. García-Sastre A., Palese P. Genetic manipulation of negative-strand RNA virus genomes. Annu Rev Microbiol. 1993;47:765–790. doi: 10.1146/annurev.mi.47.100193.004001. [DOI] [PubMed] [Google Scholar]
  15. Gorman C. M., Moffat L. F., Howard B. H. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol. 1982 Sep;2(9):1044–1051. doi: 10.1128/mcb.2.9.1044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gregoriades A., Christie T., Markarian K. The membrane (M1) protein of influenza virus occurs in two forms and is a phosphoprotein. J Virol. 1984 Jan;49(1):229–235. doi: 10.1128/jvi.49.1.229-235.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Honda A., Uéda K., Nagata K., Ishihama A. RNA polymerase of influenza virus: role of NP in RNA chain elongation. J Biochem. 1988 Dec;104(6):1021–1026. doi: 10.1093/oxfordjournals.jbchem.a122569. [DOI] [PubMed] [Google Scholar]
  18. Kemp B. E., Pearson R. B. Protein kinase recognition sequence motifs. Trends Biochem Sci. 1990 Sep;15(9):342–346. doi: 10.1016/0968-0004(90)90073-k. [DOI] [PubMed] [Google Scholar]
  19. Kingsbury D. W., Jones I. M., Murti K. G. Assembly of influenza ribonucleoprotein in vitro using recombinant nucleoprotein. Virology. 1987 Feb;156(2):396–403. doi: 10.1016/0042-6822(87)90419-3. [DOI] [PubMed] [Google Scholar]
  20. Kingsbury D. W., Webster R. G. Some properties of influenza virus nucleocapsids. J Virol. 1969 Sep;4(3):219–225. doi: 10.1128/jvi.4.3.219-225.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kistner O., Müller H., Becht H., Scholtissek C. Phosphopeptide fingerprints of nucleoproteins of various influenza A virus strains grown in different host cells. J Gen Virol. 1985 Mar;66(Pt 3):465–472. doi: 10.1099/0022-1317-66-3-465. [DOI] [PubMed] [Google Scholar]
  22. Kistner O., Müller K., Scholtissek C. Differential phosphorylation of the nucleoprotein of influenza A viruses. J Gen Virol. 1989 Sep;70(Pt 9):2421–2431. doi: 10.1099/0022-1317-70-9-2421. [DOI] [PubMed] [Google Scholar]
  23. Kobayashi M., Toyoda T., Adyshev D. M., Azuma Y., Ishihama A. Molecular dissection of influenza virus nucleoprotein: deletion mapping of the RNA binding domain. J Virol. 1994 Dec;68(12):8433–8436. doi: 10.1128/jvi.68.12.8433-8436.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Lees-Miller S. P., Sakaguchi K., Ullrich S. J., Appella E., Anderson C. W. Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53. Mol Cell Biol. 1992 Nov;12(11):5041–5049. doi: 10.1128/mcb.12.11.5041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Lopez J. A., Guillen M., Sanchez-Fauquier A., Melero J. A. An antigen-binding assay to determine the specificity of monoclonal antibodies against influenza virus and mapping of epitopes. J Virol Methods. 1986 Jun;13(3):255–264. doi: 10.1016/0166-0934(86)90019-4. [DOI] [PubMed] [Google Scholar]
  26. Martin K., Helenius A. Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (M1) promotes export and inhibits import. Cell. 1991 Oct 4;67(1):117–130. doi: 10.1016/0092-8674(91)90576-k. [DOI] [PubMed] [Google Scholar]
  27. Martín J., Albo C., Ortín J., Melero J. A., Portela A. In vitro reconstitution of active influenza virus ribonucleoprotein complexes using viral proteins purified from infected cells. J Gen Virol. 1992 Jul;73(Pt 7):1855–1859. doi: 10.1099/0022-1317-73-7-1855. [DOI] [PubMed] [Google Scholar]
  28. Mena I., de la Luna S., Albo C., Martín J., Nieto A., Ortín J., Portela A. Synthesis of biologically active influenza virus core proteins using a vaccinia virus-T7 RNA polymerase expression system. J Gen Virol. 1994 Aug;75(Pt 8):2109–2114. doi: 10.1099/0022-1317-75-8-2109. [DOI] [PubMed] [Google Scholar]
  29. Petri T., Dimmock N. J. Phosphorylation of influenza virus nucleoprotein in vivo. J Gen Virol. 1981 Nov;57(Pt 1):185–190. doi: 10.1099/0022-1317-57-1-185. [DOI] [PubMed] [Google Scholar]
  30. Pons M. W., Schulze I. T., Hirst G. K., Hauser R. Isolation and characterization of the ribonucleoprotein of influenza virus. Virology. 1969 Oct;39(2):250–259. doi: 10.1016/0042-6822(69)90045-2. [DOI] [PubMed] [Google Scholar]
  31. Portela A., Jones L. D., Nuttall P. Identification of viral structural polypeptides of Thogoto virus (a tick-borne orthomyxo-like virus) and functions associated with the glycoprotein. J Gen Virol. 1992 Nov;73(Pt 11):2823–2830. doi: 10.1099/0022-1317-73-11-2823. [DOI] [PubMed] [Google Scholar]
  32. Privalsky M. L., Penhoet E. E. Influenza virus proteins: identity, synthesis, and modification analyzed by two-dimensional gel electrophoresis. Proc Natl Acad Sci U S A. 1978 Aug;75(8):3625–3629. doi: 10.1073/pnas.75.8.3625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Privalsky M. L., Penhoet E. E. Phosphorylated protein component present in influenza virions. J Virol. 1977 Oct;24(1):401–405. doi: 10.1128/jvi.24.1.401-405.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Ruigrok R. W., Baudin F. Structure of influenza virus ribonucleoprotein particles. II. Purified RNA-free influenza virus ribonucleoprotein forms structures that are indistinguishable from the intact influenza virus ribonucleoprotein particles. J Gen Virol. 1995 Apr;76(Pt 4):1009–1014. doi: 10.1099/0022-1317-76-4-1009. [DOI] [PubMed] [Google Scholar]
  35. Saffer L. D., Long Krug S. A., Schwartzman J. D. The role of phospholipase in host cell penetration by Toxoplasma gondii. Am J Trop Med Hyg. 1989 Feb;40(2):145–149. doi: 10.4269/ajtmh.1989.40.145. [DOI] [PubMed] [Google Scholar]
  36. Sanz-Ezquerro J. J., de la Luna S., Ortín J., Nieto A. Individual expression of influenza virus PA protein induces degradation of coexpressed proteins. J Virol. 1995 Apr;69(4):2420–2426. doi: 10.1128/jvi.69.4.2420-2426.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Shapiro G. I., Krug R. M. Influenza virus RNA replication in vitro: synthesis of viral template RNAs and virion RNAs in the absence of an added primer. J Virol. 1988 Jul;62(7):2285–2290. doi: 10.1128/jvi.62.7.2285-2290.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Takacs A. M., Barik S., Das T., Banerjee A. K. Phosphorylation of specific serine residues within the acidic domain of the phosphoprotein of vesicular stomatitis virus regulates transcription in vitro. J Virol. 1992 Oct;66(10):5842–5848. doi: 10.1128/jvi.66.10.5842-5848.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Whittaker G., Kemler I., Helenius A. Hyperphosphorylation of mutant influenza virus matrix protein, M1, causes its retention in the nucleus. J Virol. 1995 Jan;69(1):439–445. doi: 10.1128/jvi.69.1.439-445.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Yamanaka K., Ishihama A., Nagata K. Reconstitution of influenza virus RNA-nucleoprotein complexes structurally resembling native viral ribonucleoprotein cores. J Biol Chem. 1990 Jul 5;265(19):11151–11155. [PubMed] [Google Scholar]
  41. Zvonarjev A. Y., Ghendon Y. Z. Influence of membrane (M) protein on influenza A virus virion transcriptase activity in vitro and its susceptibility to rimantadine. J Virol. 1980 Feb;33(2):583–586. doi: 10.1128/jvi.33.2.583-586.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. de la Luna S., Martínez C., Ortín J. Molecular cloning and sequencing of influenza virus A/Victoria/3/75 polymerase genes: sequence evolution and prediction of possible functional domains. Virus Res. 1989 Jun;13(2):143–155. doi: 10.1016/0168-1702(89)90012-9. [DOI] [PubMed] [Google Scholar]
  43. van Wyke K. L., Bean W. J., Jr, Webster R. G. Monoclonal antibodies to the influenza A virus nucleoprotein affecting RNA transcription. J Virol. 1981 Jul;39(1):313–317. doi: 10.1128/jvi.39.1.313-317.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES